• Je něco špatně v tomto záznamu ?

A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms

MV. Uthaug, R. Lancelotta, K. van Oorsouw, KPC. Kuypers, N. Mason, J. Rak, A. Šuláková, R. Jurok, M. Maryška, M. Kuchař, T. Páleníček, J. Riba, JG. Ramaekers,

. 2019 ; 236 (9) : 2653-2666. [pub] 20190413

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc19044884

Grantová podpora
VI20172020056 Czech Ministery of Interior Affairs
LO1611 Czech Ministery of Education, Youth and Sports
PROGRES Q35 Charles University Prague

E-zdroje Online Plný text

NLK ProQuest Central od 1997-09-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1996-10-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 1997-09-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-09-01 do Před 1 rokem
Psychology Database (ProQuest) od 1997-09-01 do Před 1 rokem

BACKGROUND: 5-methoxy-N,N-dimethyltryptamine (hereinafter referred to as 5-MeO-DMT) is a psychedelic substance found in the secretion from the parotoid glands of the Bufo alvarius toad. Inhalation of vapor from toad secretion containing 5-MeO-DMT has become popular in naturalistic settings as a treatment of mental health problems or as a means for spiritual exploration. However, knowledge of the effects of 5-MeO-DMT in humans is limited. AIMS: The first objective of this study was to assess sub-acute and long-term effects of inhaling vapor from dried toad secretion containing 5-MeO-DMT on affect and cognition. The second objective was to assess whether any changes were associated with the psychedelic experience. METHODS: Assessments at baseline, within 24 h and 4 weeks following intake, were made in 42 individuals who inhaled vapor from dried toad secretion at several European locations. RESULTS: Relative to baseline, ratings of satisfaction with life and convergent thinking significantly increased right after intake and were maintained at follow-up 4 weeks later. Ratings of mindfulness also increased over time and reached statistical significance at 4 weeks. Ratings of depression, anxiety, and stress decreased after the session, and reached significance at 4 weeks. Participants that experienced high levels of ego dissolution or oceanic boundlessness during the session displayed higher ratings of satisfaction with life and lower ratings of depression and stress. CONCLUSION: A single inhalation of vapor from dried toad secretion containing 5-MeO-DMT produces sub-acute and long-term changes in affect and cognition in volunteers. These results warrant exploratory research into therapeutic applications of 5-MeO-DMT.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044884
003      
CZ-PrNML
005      
20200116110633.0
007      
ta
008      
200109s2019 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00213-019-05236-w $2 doi
035    __
$a (PubMed)30982127
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Uthaug, M V $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. malin.uthaug@maastrichtuniversity.nl.
245    12
$a A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms / $c MV. Uthaug, R. Lancelotta, K. van Oorsouw, KPC. Kuypers, N. Mason, J. Rak, A. Šuláková, R. Jurok, M. Maryška, M. Kuchař, T. Páleníček, J. Riba, JG. Ramaekers,
520    9_
$a BACKGROUND: 5-methoxy-N,N-dimethyltryptamine (hereinafter referred to as 5-MeO-DMT) is a psychedelic substance found in the secretion from the parotoid glands of the Bufo alvarius toad. Inhalation of vapor from toad secretion containing 5-MeO-DMT has become popular in naturalistic settings as a treatment of mental health problems or as a means for spiritual exploration. However, knowledge of the effects of 5-MeO-DMT in humans is limited. AIMS: The first objective of this study was to assess sub-acute and long-term effects of inhaling vapor from dried toad secretion containing 5-MeO-DMT on affect and cognition. The second objective was to assess whether any changes were associated with the psychedelic experience. METHODS: Assessments at baseline, within 24 h and 4 weeks following intake, were made in 42 individuals who inhaled vapor from dried toad secretion at several European locations. RESULTS: Relative to baseline, ratings of satisfaction with life and convergent thinking significantly increased right after intake and were maintained at follow-up 4 weeks later. Ratings of mindfulness also increased over time and reached statistical significance at 4 weeks. Ratings of depression, anxiety, and stress decreased after the session, and reached significance at 4 weeks. Participants that experienced high levels of ego dissolution or oceanic boundlessness during the session displayed higher ratings of satisfaction with life and lower ratings of depression and stress. CONCLUSION: A single inhalation of vapor from dried toad secretion containing 5-MeO-DMT produces sub-acute and long-term changes in affect and cognition in volunteers. These results warrant exploratory research into therapeutic applications of 5-MeO-DMT.
650    _2
$a aplikace inhalační $7 D000280
650    _2
$a dospělí $7 D000328
650    _2
$a zvířata $7 D000818
650    _2
$a ropuchy $7 D002025
650    _2
$a kognice $x účinky léků $x fyziologie $7 D003071
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a halucinogeny $x aplikace a dávkování $7 D006213
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a duševní poruchy $x farmakoterapie $x epidemiologie $x psychologie $7 D001523
650    _2
$a methoxydimethyltryptaminy $x aplikace a dávkování $7 D008732
650    _2
$a všímavost $x metody $7 D064866
650    12
$a osobní uspokojení $7 D010549
650    _2
$a vaping $x psychologie $7 D000072137
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Lancelotta, R $u Innate Path, Lakewood, CO, USA.
700    1_
$a van Oorsouw, K $u Department of Clinical Sciences, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
700    1_
$a Kuypers, K P C $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
700    1_
$a Mason, N $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
700    1_
$a Rak, J $u National Institute of Mental Health, Prague, Czech Republic. 1st Faculty of Medicine, Charles University, Prague, Czech Republic. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czech Republic.
700    1_
$a Šuláková, A $u National Institute of Mental Health, Prague, Czech Republic. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czech Republic.
700    1_
$a Jurok, R $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czech Republic. Department of Organic Chemistry, University of Chemistry and Technology, Prague, Czech Republic.
700    1_
$a Maryška, M $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czech Republic.
700    1_
$a Kuchař, M $u National Institute of Mental Health, Prague, Czech Republic. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czech Republic.
700    1_
$a Páleníček, T $u National Institute of Mental Health, Prague, Czech Republic. 3rd Faculty of Medicine, Charles University in Prague, Ruská 87, 10000, Prague 10, Czech Republic.
700    1_
$a Riba, J $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
700    1_
$a Ramaekers, J G $u Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands. j.ramaekers@maastrichtuniversity.nl.
773    0_
$w MED00003990 $t Psychopharmacology $x 1432-2072 $g Roč. 236, č. 9 (2019), s. 2653-2666
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30982127 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200116111007 $b ABA008
999    __
$a ok $b bmc $g 1483153 $s 1083557
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 236 $c 9 $d 2653-2666 $e 20190413 $i 1432-2072 $m Psychopharmacology $n Psychopharmacology $x MED00003990
GRA    __
$a VI20172020056 $p Czech Ministery of Interior Affairs
GRA    __
$a LO1611 $p Czech Ministery of Education, Youth and Sports
GRA    __
$a PROGRES Q35 $p Charles University Prague
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...